Abstract: The present disclosure provides a method for producing a population of regulatory T cells comprising culturing an initial population of regulatory T cells obtained from umbilical cord blood in a media comprising an oligonucleotide having the sequence of AATCGTAACCGTCGTATCGGCGAT (SEQ ID NO: 1) to expand the initial population of regulatory T cells, and a method of treating an autoimmune disease comprising administering to a subject in need thereof an effective amount of a composition comprising the regulatory T cells prepared by the above method.
Type:
Grant
Filed:
March 31, 2022
Date of Patent:
March 7, 2023
Assignee:
TERAIMMUNE, INC.
Inventors:
Yong Chan Kim, Nari Byun, Jeong Heon Yoon
Abstract: The present disclosure provides a method for producing a population of regulatory T cells comprising culturing an initial population of regulatory T cells obtained from umbilical cord blood in a media comprising an oligonucleotide having the sequence of AATCGTAACCGTCGTATCGGCGAT (SEQ ID NO: 1) to expand the initial population of regulatory T cells, and a method of treating an autoimmune disease comprising administering to a subject in need thereof an effective amount of a composition comprising the regulatory T cells prepared by the above method.
Type:
Application
Filed:
March 31, 2022
Publication date:
October 13, 2022
Applicant:
TERAIMMUNE, INC.
Inventors:
Yong Chan KIM, Nari BYUN, Jeong Heon YOON